HOUSTON, Sept. 3, 2019 /PRNewswire/ -- The Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Children's Hospital and Leica Microsystems, Inc. combined efforts to establish the Leica Microsystems Center of Excellence at the NRI. The new Center will support a mission to drive new discoveries and insights from scientific research performed using the ima

SEATTLE, Sept. 3, 2019 /PRNewswire/ -- Fred Hutchinson Cancer Research Center (Fred Hutch) and Leica Microsystems, Inc. have combined efforts to establish the Leica Microsystems Center of Excellence at Fred Hutch. The new Center will support a mission to drive new discoveries and insights from scientific research performed using the imaging systems.

KING OF PRUSSIA, Pa., Sept. 3, 2019 /PRNewswire/ -- With a raging opioid epidemic in the U.S. and millions of leftover prescripti

LAS VEGAS, Sept. 3, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced that it has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the pending applications, the DEA intends to distribute regulations that govern the program of growing marijuana for scientific research under DEA registration.&nb

SAN JOSE, Calif., Sept. 3, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, today announced results from the Company's first-in-patient Phase 2 clinical trial evaluating AR-105, a fully human I

NEW YORK, Sept. 3, 2019 /PRNewswire/ -- The presence of chemicals made as the body breaks down fats, proteins, and carbohydrates can predict whether Sept. 11, 2001 first responders exposed to toxic dust at the World Trade Center site subsequently develop lung disease, a new study finds.

KRAKOW, Poland, Sept. 3, 2019 /PRNewswire/ -- Selvita (WSE: SLV) today announced that Pawel Przewiezlikowski, Chief Executive Officer, will present at the following conferences in New York: Event: H.C. Wainwright 21st Annual Global Investment Conference, Sept. 8-10, 2019

TAIPEI, Taiwan, Sept. 3, 2019 /PRNewswire/ -- OBI Pharma, a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for OBI-999 to conduct a Phase 1/2 study of its antibody drug conjugate (ADC) cancer therapy targeting Globo H, a

PARAMUS, N.J., Sept. 3, 2019 /PRNewswire/ -- Sony plans to release a new, more user-friendly workflow version of its modality-neutral NUCLeUS™ medical imaging plat

LINKÖPING, Sweden, Sept. 3, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) reported growth in all operating areas du